Literature DB >> 10768210

Apoptosis in systemic lupus erythematosus. Clinical implications.

F Andrade1, L Casciola-Rosen, A Rosen.   

Abstract

SLE is a heterogeneous and complex group of disorders of uncertain cause. Recent studies have suggested that abnormalities in the apoptotic cell death process may play an important role in the initiation and propagation of this spectrum of disease by altering the generation and cleavage of antigens, and through abnormalities in immunoregulation. The clustering and concentration of autoantigens in and on the surface blebs of apoptotic cells, modifications of antigen structure during certain forms of apoptotic death, and abnormalities in apoptotic cell clearance in humans with SLE and in certain animal models are reviewed and synthesized into a comprehensive model of systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10768210     DOI: 10.1016/s0889-857x(05)70136-8

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  23 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

2.  Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.

Authors:  B A Cocca; S N Seal; P D'Agnillo; Y M Mueller; P D Katsikis; J Rauch; M Weigert; M Z Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Autoantigenesis: the evolution of protein modifications in autoimmune disease.

Authors:  Hester A Doyle; Mark J Mamula
Journal:  Curr Opin Immunol       Date:  2011-12-29       Impact factor: 7.486

4.  Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.

Authors:  Kavita M Dhodapkar; Scott Barbuto; Phillip Matthews; Anjli Kukreja; Amitabha Mazumder; David Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

Review 5.  The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Maria Helena Bittencourt Kiss
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

6.  A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.

Authors:  Felipe Andrade; Livia A Casciola-Rosen; Antony Rosen
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex.

Authors:  P Macdonald; J Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

8.  Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?

Authors:  A A Bengtsson; G Sturfelt; B Gullstrand; L Truedsson
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

9.  A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen.

Authors:  Dahai Xue; Hong Shi; James D Smith; Xinguo Chen; Dennis A Noe; Tommy Cedervall; Derek D Yang; Elizabeth Eynon; Douglas E Brash; Michael Kashgarian; Richard A Flavell; Sandra L Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-03       Impact factor: 11.205

10.  NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus.

Authors:  Allison M Campbell; Michael Kashgarian; Mark J Shlomchik
Journal:  Sci Transl Med       Date:  2012-10-24       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.